documents: FDA-2010-P-0624-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-P-0624-0008 FDA FDA-2010-P-0624 Exhibit 26 - "Cubist Letter to FDA/CDER, September 14, 2000 re Change in Manufacturer Procedure for Daptomycin API" - [Cubist Pharmaceuticals, Inc. - Supplement] re FDA-2010-P-0624-0005 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-02-15T05:00:00Z 2011 2     2011-02-16T00:31:19Z   0 0 0900006480bcda9d

Links from other tables